Download FREE Report Sample
Download Free sampleHIV/AIDS is one of the most serious chronic diseases and the high prevalence of the disease in almost all parts of the world has resulted in an unprecedented awareness regarding the disease.
Drugs for HIV Market contains market size and forecasts of Drugs for HIV in global, including the following market information:
Global Drugs for HIV Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Drugs for HIV Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Drugs for HIV companies in 2021 (%)
The global Drugs for HIV market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Drugs for HIV include ViiV Healthcare, Gilead Sciences, Inc, Merck Sharp & Dohme Corp, Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Theratechnologies Inc., Mylan Pharmaceuticals Inc., Genentech, Inc. and AbbVie Inc.. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drugs for HIV manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for HIV Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Drugs for HIV Market Segment Percentages, by Type, 2021 (%)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Integrase Inhibitors
Combination HIV Medicines
Others
Global Drugs for HIV Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Drugs for HIV Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Global Drugs for HIV Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Drugs for HIV Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs for HIV revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Drugs for HIV revenues share in global market, 2021 (%)
Key companies Drugs for HIV sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Drugs for HIV sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
ViiV Healthcare
Gilead Sciences, Inc
Merck Sharp & Dohme Corp
Bristol-Myers Squibb Company
Janssen Pharmaceuticals, Inc.
Theratechnologies Inc.
Mylan Pharmaceuticals Inc.
Genentech, Inc.
AbbVie Inc.
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
